• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病客观运动障碍评定量表的效用:评定者间和评定者内信度评估

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

作者信息

Goetz C G, Stebbins G T, Shale H M, Lang A E, Chernik D A, Chmura T A, Ahlskog J E, Dorflinger E E

机构信息

Department of Neurological Sciences, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois.

出版信息

Mov Disord. 1994 Jul;9(4):390-4. doi: 10.1002/mds.870090403.

DOI:10.1002/mds.870090403
PMID:7969204
Abstract

Although dyskinesia is a frequent and important problem in Parkinson's disease (PD), a reliable assessment measure has not been thoroughly developed and tested. We modified the Obeso dyskinesia scale to create an objective rating scale for dyskinesia assessment during activities of daily living. Thirteen physicians and 15 study coordinators involved in a clinical trial independently reviewed videotape segments of PD patients performing three tasks: walking, putting on a coat, and lifting a cup to the lips for drinking. Raters evaluated the severity of worst dyskinesia seen, the types of all dyskinesias seen, and the type of dyskinesia most associated with motoric disability. For all assessments, the total group showed statistically significant inter- and intrarater reliability. Physicians had a higher consistency than did coordinators, but for most measures the difference was not statistically significant. Physicians and coordinators found the scale easy to use and especially practical for rating dyskinesia severity and for identifying the most disabling dyskinesia. Dyskinesias can be assessed in clinical trials and warrant regular documentation.

摘要

尽管异动症在帕金森病(PD)中是一个常见且重要的问题,但尚未充分开发和测试出一种可靠的评估方法。我们对奥贝索异动症量表进行了修改,以创建一种用于在日常生活活动中评估异动症的客观评分量表。参与一项临床试验的13名医生和15名研究协调员独立审查了帕金森病患者执行三项任务(行走、穿外套、将杯子举到嘴边喝水)的录像片段。评分者评估了所观察到的最严重异动症的严重程度、所观察到的所有异动症的类型,以及与运动障碍最相关的异动症类型。对于所有评估,总体组在评分者间和评分者内均显示出具有统计学意义的可靠性。医生的一致性高于协调员,但对于大多数指标,差异无统计学意义。医生和协调员发现该量表易于使用,尤其适用于评估异动症严重程度和识别最具致残性的异动症。异动症可在临床试验中进行评估,并且需要定期记录。

相似文献

1
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.帕金森病客观运动障碍评定量表的效用:评定者间和评定者内信度评估
Mov Disord. 1994 Jul;9(4):390-4. doi: 10.1002/mds.870090403.
2
Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.早期帕金森病患者统一帕金森病评定量表的重测信度:一项多中心临床试验的结果
Mov Disord. 2002 Jul;17(4):758-63. doi: 10.1002/mds.10011.
3
Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.帕金森病的分级损伤与残疾:统一帕金森病评定量表评估
Mov Disord. 1994 Jan;9(1):84-8. doi: 10.1002/mds.870090113.
4
Teaching program for the Unified Dyskinesia Rating Scale.统一运动障碍评定量表教学方案
Mov Disord. 2009 Jul 15;24(9):1296-8. doi: 10.1002/mds.22563.
5
Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination.统一帕金森病评定量表运动检查的评分者间信度。
Mov Disord. 1994 Jan;9(1):89-91. doi: 10.1002/mds.870090114.
6
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.降低卡比多巴/左旋多巴的给药频率:双盲交叉研究,比较卡比多巴/左旋多巴每日两次双层制剂(IPX054)与稳定期帕金森病患者每日4次标准卡比多巴/左旋多巴的疗效。
Clin Neuropharmacol. 2009 Jul-Aug;32(4):189-92. doi: 10.1097/WNF.0b013e3181a27fae.
7
The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.统一运动障碍评定量表:介绍与临床测量概况。
Mov Disord. 2008 Dec 15;23(16):2398-403. doi: 10.1002/mds.22341.
8
Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.帕金森病统一评定量表病史部分患者完成情况的可靠性。
Mov Disord. 1996 Mar;11(2):185-92. doi: 10.1002/mds.870110212.
9
Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks.神经网络在日常生活中对左旋多巴诱导的异动症进行自动评估。
Mov Disord. 2003 Jan;18(1):70-80. doi: 10.1002/mds.10310.
10
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.帕金森病功能障碍和残疾评定量表的系统评价
Mov Disord. 2002 Sep;17(5):867-76. doi: 10.1002/mds.10248.

引用本文的文献

1
Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review.帕金森病、进行性核上性麻痹和多系统萎缩中与健康相关生活质量评估量表的系统评价
Front Psychol. 2024 Sep 10;15:1438830. doi: 10.3389/fpsyg.2024.1438830. eCollection 2024.
2
Fundamentals of deep brain stimulation for Parkinson's disease in clinical practice: part 1.临床实践中帕金森病深部脑刺激的基础:第1部分。
Arq Neuropsiquiatr. 2024 Apr;82(4):1-9. doi: 10.1055/s-0044-1786026. Epub 2024 Apr 23.
3
Efficacy and safety of adjunctive oral therapy in Parkinson's disease with motor complications: a systematic review and network meta-analysis.
帕金森病运动并发症辅助口服治疗的疗效与安全性:一项系统评价和网状Meta分析
BMJ Neurol Open. 2024 Feb 10;6(1):e000573. doi: 10.1136/bmjno-2023-000573. eCollection 2024.
4
Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's disease.中国帕金森病队列中GBA1基因变异的突变谱及临床特征
NPJ Parkinsons Dis. 2023 Sep 1;9(1):129. doi: 10.1038/s41531-023-00571-4.
5
The Use of Liquid Sinemet in Routine Clinical Practice of Advanced Parkinson's Disease: A Comparison of Available Options.在晚期帕金森病的常规临床实践中使用液体 Sinemet:可用选择的比较。
J Parkinsons Dis. 2023;13(4):609-617. doi: 10.3233/JPD-225117.
6
The benefits of tourism for rural community development.旅游业对农村社区发展的益处。
Humanit Soc Sci Commun. 2023;10(1):137. doi: 10.1057/s41599-023-01610-4. Epub 2023 Mar 31.
7
Overall Efficacy and Safety of Safinamide in Parkinson's Disease: A Systematic Review and a Meta-analysis.总体疗效和安全性的沙芬酰胺在帕金森病:系统评价和荟萃分析。
Clin Drug Investig. 2021 Apr;41(4):321-339. doi: 10.1007/s40261-021-01011-y. Epub 2021 Mar 5.
8
The Parkinson's Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge.帕金森病综合量表对急性左旋多巴激发试验有足够的反应性。
Parkinsons Dis. 2019 Sep 10;2019:1412984. doi: 10.1155/2019/1412984. eCollection 2019.
9
A Validation Study of Freezing of Gait (FoG) Detection and Machine-Learning-Based FoG Prediction Using Estimated Gait Characteristics with a Wearable Accelerometer.使用可穿戴加速度计估算的步态特征进行冻结步态(FoG)检测和基于机器学习的 FoG 预测的验证研究。
Sensors (Basel). 2018 Sep 30;18(10):3287. doi: 10.3390/s18103287.
10
Can Rehabilitation Influence the Efficiency of Control Signals in Complex Motion Strategies?康复治疗是否会影响复杂运动策略中的控制信号效率?
Biomed Res Int. 2017;2017:3631624. doi: 10.1155/2017/3631624. Epub 2017 May 24.